Armando Flor, MD
MedImmune, Gaithersburg, Maryland

Dr. Armando Flor joined MedImmune, an AstraZeneca Company, from GSK in January 2013.  He is an Endocrinologist and the medical director for clinical trials for Type 2 Diabetes and Obesity. 

Dr. Flor received his medical degree from the Central University of Ecuador, completed residency training in pediatrics at Winthrop University Hospital, NY, and completed his endocrinology fellowship at the NIH (National Institute of Child and Human Development, NICHD).